Glucagon-like peptide 1 receptor agonist

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Glucagon-like peptide 1 receptor agonist
Treatment and conditionWhere it standsTrials
Glucagon-like peptide 1 receptor agonist for endometrial neoplasmsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1